112 related articles for article (PubMed ID: 38486461)
1. Network-base approaches to identify therapeutic biomarkers in hepatocellular carcinoma and search for drug hunting utilizing molecular dynamics simulations.
Ayaz H; Ahmad F; Ahmad S; Arfan Q; Alasmari AF; Siddique F; Rehman B; Zeb A; Crovella S; Ali SS; Waheed Y; Suleman M
J Biomol Struct Dyn; 2024 Mar; ():1-17. PubMed ID: 38486461
[TBL] [Abstract][Full Text] [Related]
2. Network pharmacology and experimental validation for deciphering the action mechanism of
Bhat BA; Rashid Mir W; Alkhanani M; Almilaibary A; Mir MA
J Biomol Struct Dyn; 2023 Nov; ():1-21. PubMed ID: 37948293
[No Abstract] [Full Text] [Related]
3. In silico study on anti-Chikungunya virus activity of hesperetin.
Oo A; Hassandarvish P; Chin SP; Lee VS; Abu Bakar S; Zandi K
PeerJ; 2016; 4():e2602. PubMed ID: 27812412
[TBL] [Abstract][Full Text] [Related]
4. Integrated network analysis to identify the key genes, transcription factors, and microRNAs involved in hepatocellular carcinoma.
Shi SQ; Ke JJ; Xu QS; Wu WQ; Wan YY
Neoplasma; 2018; 65(1):66-74. PubMed ID: 29322790
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Gene expression analysis reveals GRIN1, SYT1, and SYN2 as significant therapeutic targets and drug repurposing reveals lorazepam and lorediplon as potent inhibitors to manage Alzheimer's disease.
T P; Katta B; Lulu S S; Sundararajan V
J Biomol Struct Dyn; 2023 Sep; ():1-22. PubMed ID: 37691428
[TBL] [Abstract][Full Text] [Related]
7. Molecular docking and dynamic simulations of
Sangeetha R; Arockia Jeya Yasmi Prabha E; Lakshmi A; Sangavi P; Langeswaran K
J Biomol Struct Dyn; 2022; 40(24):13997-14012. PubMed ID: 34738880
[TBL] [Abstract][Full Text] [Related]
8. A novel therapeutic approach to prevent
Khan N; Rehman B; Almanaa TN; Aljahdali SM; Waheed Y; Ullah A; Asfandayar M; Al-Harbi AI; Naz T; Arshad M; Sanami S; Ahmad S
J Biomol Struct Dyn; 2023 Nov; ():1-14. PubMed ID: 37962871
[No Abstract] [Full Text] [Related]
9. Integrated gene expression profiling and functional enrichment analyses to discover biomarkers and pathways associated with Guillain-Barré syndrome and autism spectrum disorder to identify new therapeutic targets.
Hasib RA; Ali MC; Rahman MH; Ahmed S; Sultana S; Summa SZ; Shimu MSS; Afrin Z; Jamal MAHM
J Biomol Struct Dyn; 2023 Sep; ():1-23. PubMed ID: 37776011
[TBL] [Abstract][Full Text] [Related]
10. Active ingredients and molecular targets of
Zheng Y; Ji S; Li X; Feng Q
PeerJ; 2022; 10():e13737. PubMed ID: 35873910
[TBL] [Abstract][Full Text] [Related]
11. Structure-based molecular docking and molecular dynamics simulations study for the identification of dipeptidyl peptidase 4 inhibitors in type 2 diabetes.
Chen X; Xue B; Wahab S; Sultan A; Khalid M; Yang S
J Biomol Struct Dyn; 2023 Dec; ():1-14. PubMed ID: 38100564
[TBL] [Abstract][Full Text] [Related]
12. Network metrics, structural dynamics and density functional theory calculations identified a novel Ursodeoxycholic Acid derivative against therapeutic target Parkin for Parkinson's disease.
Naha A; Banerjee S; Debroy R; Basu S; Ashok G; Priyamvada P; Kumar H; Preethi AR; Singh H; Anbarasu A; Ramaiah S
Comput Struct Biotechnol J; 2022; 20():4271-4287. PubMed ID: 36051887
[TBL] [Abstract][Full Text] [Related]
13. Identifying potential inhibitors of C-X-C motif chemokine ligand10 against vitiligo: structure-based virtual screening, molecular dynamics simulation, and principal component analysis.
Khan MKA; Alouffi S; Ahmad S
J Biomol Struct Dyn; 2023 Aug; ():1-18. PubMed ID: 37565326
[TBL] [Abstract][Full Text] [Related]
14. Screening and Functional Prediction of Key Candidate Genes in Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Chen X; Liao L; Li Y; Huang H; Huang Q; Deng S
Biomed Res Int; 2020; 2020():7653506. PubMed ID: 33102593
[TBL] [Abstract][Full Text] [Related]
15. Utilizing the drug repurposing strategy on current drugs: new leads for peptic ulcers
Khan M; Nizamani A; Shah L; Ullah I; Waqas M; Halim SA; Ataya FS; Elgazzar AM; Batiha GE; Khan A; Al-Harrasi A
J Biomol Struct Dyn; 2024 Jan; ():1-14. PubMed ID: 38225797
[TBL] [Abstract][Full Text] [Related]
16. Screening of significant biomarkers with poor prognosis in hepatocellular carcinoma via bioinformatics analysis.
Sun Q; Liu P; Long B; Zhu Y; Liu T
Medicine (Baltimore); 2020 Aug; 99(32):e21702. PubMed ID: 32769939
[TBL] [Abstract][Full Text] [Related]
17. Unlocking therapeutic potential: computational insights into TREM2 protein targeting with FDA-approved drugs for neurodegeneration.
Alrouji M; Yasmin S; Alhumaydhi FA; Sharaf SE; Shahwan M; Shamsi A
J Biomol Struct Dyn; 2024 Feb; ():1-11. PubMed ID: 38373093
[TBL] [Abstract][Full Text] [Related]
18. Network pharmacology, molecular simulation, and binding free energy calculation-based investigation of Neosetophomone B revealed key targets for the treatment of cancer.
Khan A; Waheed Y; Kuttikrishnan S; Prabhu KS; El-Elimat T; Uddin S; Alali FQ; Agouni A
Front Pharmacol; 2024; 15():1352907. PubMed ID: 38434705
[TBL] [Abstract][Full Text] [Related]
19. The role of differentially expressed genes and immune cell infiltration in the progression of nonalcoholic steatohepatitis (NASH) to hepatocellular carcinoma (HCC): a new exploration based on bioinformatics analysis.
Liu Y; Yu X; Wang Y; Wu J; Feng B; Li M
Nucleosides Nucleotides Nucleic Acids; 2024 Feb; ():1-16. PubMed ID: 38319987
[TBL] [Abstract][Full Text] [Related]
20. Bioinformatics analysis reveals meaningful markers and outcome predictors in HBV-associated hepatocellular carcinoma.
Zhang L; Makamure J; Zhao D; Liu Y; Guo X; Zheng C; Liang B
Exp Ther Med; 2020 Jul; 20(1):427-435. PubMed ID: 32537007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
